Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)
This study is currently recruiting participants.
Verified March 2013 by Nanjing University School of Medicine
Zhi-Hong Liu, M.D.
Nanjing Medical University
Information provided by (Responsible Party):
Zhi-Hong Liu, M.D., Nanjing University School of Medicine
First received: January 3, 2011
Last updated: March 29, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||April 2015|
|Estimated Primary Completion Date:||April 2014 (Final data collection date for primary outcome measure)|